Proof-of-concept study on the suitability of 13C-urea as a marker substance for assessment of in vivo behaviour of oral colon-targeted dosage forms
AUTOR(ES)
Schellekens, RCA
FONTE
Blackwell Publishing Ltd
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2757693Documentos Relacionados
- Methadone in post-herpetic neuralgia: A pilot proof-of-concept study
- Design and preparation of a novel colon-targeted tablet of hydrocortisone
- Design and preparation of a novel colon-targeted tablet of hydrocortisone
- Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial
- 13C-Urea breath test threshold calculation and evaluation for the detection of Helicobacter pylori infection in children